Ranked #7,804 of 8,699 institutional investors
KVP Capital Advisors, LP
San Francisco, CA
$116M
US stock portfolio at live prices · today −$1.5M (−1.30%)
Live prices, last trade 11:09 AM ET
- Value at quarter end (Q3 2026)
- $124M
- Change from Q2 2026
- −$11.9M (−8.77%)
- Positions
- 34 · 3 new, 2 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$2.4M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSLN 11.7%PRAX 11.4%WHWK 5.80%PTGX 5.59%MBX 5.46%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SLN Silence Therapeutics plc | 684,123 | $13.5M | 11.7% | New |
| PRAX Praxis Precision Medicines, Inc. | 42,900 | $13.2M | 11.4% | Unchanged |
| WHWK Whitehawk Therapeutics, Inc. | 2,165,997 | $6.7M | 5.80% | Unchanged |
| PTGX Protagonist Therapeutics, Inc. | 53,000 | $6.5M | 5.59% | Unchanged |
| MBX MBX Biosciences, Inc. | 121,524 | $6.3M | 5.46% | Unchanged |
| ERAS Erasca, Inc. | 455,000 | $6.3M | 5.44% | Unchanged |
| TRVI Trevi Therapeutics, Inc. | 414,000 | $5.6M | 4.82% | Unchanged |
| EWTX Edgewise Therapeutics, Inc. | 133,000 | $5.4M | 4.66% | Unchanged |
| TNDM Tandem Diabetes Care, Inc. | 301,000 | $5.3M | 4.61% | Unchanged |
| TNGX Tango Therapeutics, Inc. | 230,264 | $5.2M | 4.48% | Unchanged |
| INSM Insmed Incorporated | 28,497 | $4.2M | 3.60% | Unchanged |
| VRDN Viridian Therapeutics, Inc. | 125,000 | $3.9M | 3.34% | Unchanged |
| IRON Disc Medicine, Inc. | 43,750 | $3.3M | 2.83% | Reduced −25% |
| QUIT Achieve Life Sciences, Inc. | 462,355 | $2.7M | 2.30% | Unchanged |
| UTHR United Therapeutics Corporation | 4,750 | $2.6M | 2.27% | Unchanged |
| SVRA Savara Inc. | 605,280 | $2.6M | 2.26% | Unchanged |
| IDYA IDEAYA Biosciences, Inc. | 79,700 | $2.1M | 1.80% | Unchanged |
| STRO Sutro Biopharma, Inc. | 226,575 | $2.0M | 1.73% | Unchanged |
| TVTX Travere Therapeutics, Inc. | 39,000 | $1.9M | 1.63% | Unchanged |
| OCUL Ocular Therapeutix, Inc. | 300,000 | $1.7M | 1.48% | Unchanged |
| DSGN Design Therapeutics, Inc. | 185,000 | $1.7M | 1.48% | Unchanged |
| IMMX Immix Biopharma, Inc. | 230,423 | $1.7M | 1.46% | Unchanged |
| MLYS Mineralys Therapeutics, Inc. | 84,168 | $1.2M | 1.03% | Unchanged |
| AVBP ArriVent BioPharma, Inc. | 102,000 | $1.1M | 0.97% | Unchanged |
| VOGX Vogenx, Inc. | 86,069 | $1.1M | 0.94% | New |
| EOLS Evolus, Inc. | 150,000 | $1.1M | 0.91% | Unchanged |
| NKTR Nektar Therapeutics | 26,900 | $849K | 0.73% | Unchanged |
| VERA Vera Therapeutics, Inc. | 32,700 | $847K | 0.73% | Unchanged |
| ARTV Artiva Biotherapeutics, Inc. | 200,000 | $769K | 0.67% | Unchanged |
| DRUG Bright Minds Biosciences Inc. | 31,813 | $674K | 0.58% | Unchanged |
| CMPX Compass Therapeutics, Inc. | 771,000 | $532K | 0.46% | Unchanged |
| CABA Cabaletta Bio, Inc. | 505,431 | $499K | 0.43% | Unchanged |
| CELC Celcuity Inc. | 4,000 | $220K | 0.19% | Unchanged |
| YARW Yarrow Bioscience, Inc. | 10,011 | $138K | 0.12% | New |